45 studies found for:    " May 19, 2010":" June 18, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: LPV/r
22 Not yet recruiting Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection
Conditions: Hepatitis C, Chronic;   HIV Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
23 Completed A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761;   Drug: Simvastatin;   Drug: Atorvastatin;   Drug: Rosuvastatin
24 Completed The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children
Conditions: HIV Infections;   Varicella-Zoster Virus
Intervention: Biological: VZV vaccination
25 Completed Male Involvement in Antenatal Care and the Prevention Programme of Mother-to-child Transmission of HIV in Uganda
Condition: HIV Infection
Interventions: Behavioral: Invitation letter for male spouse;   Behavioral: Information letter
26 Completed Treatment Options for Protease Inhibitor-exposed Children
Conditions: HIV/AIDS;   HIV Infections
Interventions: Drug: Efavirenz;   Drug: Lopinavir/ritonavir (LPV/r);   Drug: D4T;   Drug: Abacavir (ABC)
27 Active, not recruiting Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)
Condition: HIV Infections
Intervention: Drug: ATV/r
28 Completed Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children
Condition: HIV-1 Infections
Intervention: Other: lopinavir/ritonavir
29 Completed Lopinavir (LPV) Dose Reduction
Condition: HIV-1 Infections
Interventions: Drug: Generic LPV/r and Aluvia (pharmacokinetics);   Drug: Aluvia and Generic LPV/r (pharmacokinetics)
30 Completed Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults
Condition: HIV-1 Infection in Adults (Asymptomatic)
Intervention: Drug: Antibody UB-421
31 Completed Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia
Condition: HIV
Intervention:
32 Completed Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in Malawi
Condition: HIV
Interventions: Drug: Copper IUD;   Drug: Depo Medroxyprogesterone acetate
33 Recruiting Selective Exposure in HIV Prevention
Condition: HIV Infections
Interventions: Other: Instrumental meta intervention;   Other: Empowering meta-intervention;   Other: Control
34 Completed A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring
Condition: HIV Infections
Interventions: Drug: dapivirine;   Drug: placebo
35 Completed Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)
Condition: HIV Infections
Intervention:
36 Completed Tenofovir Gel in Pregnancy and Lactation
Condition: HIV Infections
Interventions: Drug: Tenofovir 1% gel;   Other: Placebo gel
37 Completed
Has Results
Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific Data
Condition: HIV Infections
Intervention:
38 Active, not recruiting Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico
Conditions: Drug Abuse;   HIV Risk Behavior
Interventions: Behavioral: Computerized brief intervention;   Behavioral: Counselor delivered brief intervention
39 Completed Dermal HIV-1 Immunization During Anti-retroviral Therapy Followed by Repeated Treatment Interruptions
Condition: HIV-1
Intervention: Biological: HIV DNA Vaccine
40 Terminated
Has Results
Pregabalin Trial In HIV Neuropathic Pain
Conditions: HIV-1 Infection;   Neuropathic Pain
Intervention: Drug: pregabalin (Lyrica)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results    Last Page
Indicates status has not been verified in more than two years